chrisvoncsefalvay/vaers-outcomes huggingface dataset:
We have information concerning a member that received the Moderna Vaccine (first dose) on Sunday April 11, 2021; Patient denied any side effect immediately following vaccination. However on Sunday April 18, 2021 , patient had complains of shortness of breath, chest pain. At which time presented to the Hospital and was admitted on Sunday April 18, 2021 with a diagnosis of Pulmonary Embolism. Patient remains hospitalized as receiving treatment of blood thinner, and embolectomy procedure.
h/a & arm was red, swollen & hot to touch; arm very bothersome; h/a did not concern pt as much;
Felt "Paralyzed" in hands with contractures from wrist to fingers.  Nausea, Legs shaky.  See IR
Extremely tired and  Very cold and shivering off and on for 48 hours (so far)
Patient presented to the ED with shortness of breath and was subsequently hospitalized with COVID-19 pneumonia. This was within 6 weeks of receiving COVID vaccination.
pt admitted to hospital due to traumatic subdural hemorrhage; tested positive for COVID while in the facility and had a steady decline in his condition; died in the hospital with COVID-19 being the cause of death
Both Sore arms, unable to lift arms. Xray was done on 10/6/2020.
Red/Hot area & extreme itching  for 1 week 2 days so far. Lump under skin has increased in size x's 3. Never had severe pain with moving arm.
10 minutes after vaccine administration-complained of headache, blood  pressure taken 158/111 pulse76, O2 sat 99%,  Patient then told healthcare providers he had not taken any of his daily (morning) meds and had not eaten, offender was sent to hospital by ambulance
48 hours of vaccine receipt, patient complained of a rash about 4 inches widex4 inches long around the vaccine site. Also had complaints of warmth, redness, and tender to the touch.
Injection site redness; Chills; Fatigue; Lymph node swelling under her armpit; Swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Injection site redness), CHILLS (Chills), FATIGUE (Fatigue), LYMPHADENOPATHY (Lymph node swelling under her armpit) and VACCINATION SITE SWELLING (Swelling at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 007M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Injection site redness), CHILLS (Chills), FATIGUE (Fatigue), LYMPHADENOPATHY (Lymph node swelling under her armpit) and VACCINATION SITE SWELLING (Swelling at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Injection site redness), CHILLS (Chills), FATIGUE (Fatigue), LYMPHADENOPATHY (Lymph node swelling under her armpit) and VACCINATION SITE SWELLING (Swelling at the injection site) outcome was unknown.            Concomitant medication were not reported. Treatment details were not provided. Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow up received on 10 MAY 2021, Non significant: Email and address was updated
Localized swelling and pain after she received a MMR vaccine on 3/19/09 in Lt. upper arm.
WITH FIRST DOSE, PATIENT REPORTED BREAKING OUT ON HER SCALP FOLLOWING SECOND DOSE OF JANUARY 2020, PATIENT REPORTED THE BREAK OUTS STARTED ITCHING AND SPREADING TO OTHER BODY PARTS. DOCTOR RULED IT AS ALLERGIC DERMATITIS WHICH PATIENT REPORTS THAT THE ONLY THING CHANGED WAS THE ADMINISTRATION OF THE VACCINE. PATIENT HAS TRIED STEROID SHOTS BY THE DOCTOR WHICH HELPED FOR 4 DAYS. PREDNISONE WAS PRECRIBED FOR OTHER VIRUS INFECTION AND HELPED CALM DOWN SYMPTOMS. DOCTOR THEN PRESCRIBED TRIAMCINALONE AND CLOBETASOL CREAM IN FEBRUARY WHICH HELPED. PATIENT HAS BEEN ON AND OFF CREAM EVERY 2 WEEKS.
1/28/22 (20 days following receipt of 3rd dose of Pfizer mRNA vaccine) vaccinee abruptly developed lower thoracic-upper lumbar back/spine pain with radiation of pain to both lower extremities, numbness/pins and needles in both lower extremities and antalgic gait
The patient lost consciousness 6 minutes after receiving the vaccine.  She fell from her chair that she was sitting on and hit her head on the ground.  The patient was still breathing and we called 911 immediately.  She regained consciousness a few minutes later, the paramedics arrived, and the patient was taken to the hospital by paramedics.
Patient received FLUZONE at 2pm on 1-26-11. By 6pm she had SOB, dizziness, fever, h/a and vomiting. She is a known asthmatic. Was given a nebulizer treatment on 1-27-11.
1 cm intracranial hemorrhage- pt had headache, episode of nausea and vomiting, headache for 8 days prior to appt with provider
This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 66-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of fatigue (received 1st dose refer case US2019013592). On 5th January 2019, the patient received the 2nd dose of SHINGRIX. On 7th January 2019, 2 days after receiving SHINGRIX, the patient experienced facial puffiness. In January 2019, the patient experienced tiredness and injection site pain. The patient was treated with HYALURONIC ACID (JUVEDERM). Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the tiredness, injection site pain and facial puffiness were unknown. It was unknown if the reporter considered the tiredness, injection site pain and facial puffiness to be related to SHINGRIX. Additional details were provided as follows: The batch number was not reported. The patient received SHINGRIX in the left arm. Less than a month after receiving vaccination, the patient reported that she had her second injection and experienced feeling tired and soreness at her injection site.  The patient planned to continue follow up with her physician on an unknown date. Consented to follow up was provided. The patient reported that her dermatologist reported this to Allergan regarding the Juvederm. This case linked with US2019013592, reported by same reporter for the same patient.
Debilitating headache lasting more than 24hrs. Red rash under skin on face, neck and torso.
PT states that immediately upon receiving vaccine that he experience extreme pain of the right arm, and "immediate pain, pressure at the cartiledge of the injection site.  Has had pain of the right shoulder since this time and also says that he has had limited rom of the arm. Has taken motrin, used ice and Tylenol with no relief of symptoms.  Has normal grip strength, reports intermittent numbness of forearm to his PCP, who he followed up with on 6/14/21
taken the flu vaccine 4-5 years ago / felt very sick; This case was reported by a consumer via licensee and described the occurrence of sickness in a female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   Concurrent medical conditions included penicillin allergy (the patient was allergic to penicillin).   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Influenza vaccine Quadrivalent unspecified season.  Additional information was provided as follows: This case was reported by patient herself. The age at vaccination was not reported. The patient received the flu vaccine 4 to 5 years ago and felt very sick. The patient was advised to check with her vaccination provider, doctor, or other qualified health care professional about whether a specific treatment or medication was right for her. The reporter's and healthcare professional s consent to follow-up was reported as not applicable.
I received my COVID-19 Booster Shot. I came home, and I felt fine. I woke up today with blurry vision that is so terrible. I regularly wear glasses.  My most recent eye exam was 1 month ago, and purchased new glasses with their new prescription. I have a great optometrist. I am scared about my vision and that it will not ever be normal again. I can?t look at anything digital, like a phone or TV because I see double. And I can?t read with my  glasses on. Also, my wife has the same thing happening to her. Whether the CDC does something or not is not in my control. But I?m a 26 years old female. I am SO scared that this may be permanent?I want a real and concrete answer about this. Not someone to apologize to me and say ?it will work out?. My wife and i will be waiting for an honest response. If you want any more info from me and/or her, you can email me. This needs to be corrected, or at least recognized immediately. Thank You, and Happy Holidays.
I am having severe kidney pain/ I mentioned it to my daughter and she too had the same pain.; This is a spontaneous report received from a contactable consumer (patient's mother).  A female patient of unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 Vaccine, Solution for injection, Lot Number: Unknown), via an unspecified route, on an unknown date, as a dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unknown date, the patient had kidney pain. The patients mother mentioned it to her daughter (severe pain in the kidney), and daughter too had the same pain. The clinical outcome of the event was unknown.  No follow-up attempts are needed. No further information expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021316651 same reporter/drug/event, different patient;US-PFIZER INC-2021305789 same reporter/drug/event, different patient
Injection site pain x 2 days, nausea x 5 days, fatigue x 3 days, chills x 2 days, muscle + joint pain x 2 days, headache x 1 day, weird dreams x 2 nights
This spontaneous report as received from a registered nurse refers to a patient of unknown gender and age. The patient was vaccinated with GARDASIL, the first dose of GARDASIL on 23-aug-2011, the second dose of GARDASIL on 09-jan-2013 and the third dose of GARDASIL on 31-jan-2013. No adverse event was reported. No further information was provided. Additional information has been requested.
red rash around the vaccine site; red rash around the vaccine site; hot to the touch; itching; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH, INJECTION SITE ERYTHEMA, INJECTION SITE WARMTH, and INJECTION SITE PRURITUS in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concomitant products included FLOVENT, LEVOTHYROXINE, and ESTRADIOL for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced INJECTION SITE RASH, INJECTION SITE ERYTHEMA, INJECTION SITE WARMTH, and INJECTION SITE PRURITUS. The patient was treated with BENADRYL at an unspecified dose and frequency and CORTISONE ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, INJECTION SITE RASH, INJECTION SITE ERYTHEMA, INJECTION SITE WARMTH, and INJECTION SITE PRURITUS outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No medical history information was provided.
first dose 3 weeks ago and 4 days after I tested positive; This is a spontaneous report from a contactable consumer or other non HCP (patient). A male patient of an unspecified age received first dose of BNT162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number and Expiry date were not reported) via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient received first dose 3 weeks ago and 4 days after patient tested positive on an unspecified date. The patient underwent lab tests and procedures on an unspecified date which included sars-cov-2 test: positive, sars-cov-2 test: clear now from the covid. Patient reported that Today he was supposed to get his second dose, was it ok to get the second dose the patient enquired. Potential AE. The outcome of the event was recovered on an unspecified date.  Information about lot/ batch number has been requested.
3 days post vax developed localized erythema, edema, & pain with circumfrencial erythema & wheal;
Left perioral and lower cheek numbness or anesthesia. Began shortly after leaving facility. Lasted 48 hours. No loss of motor function. No other symptoms.
Onset of swelling at sites of shots immediately after DTaP #1, HIB #1, IPV #1, Prevnar #1, Hep B #1. 20 minutes after shots, onset of pallor, wheezing, lethargy. Received Albuterol x 3, Ephinephrine 1:1000 0.5cc x 3 SC 10 min apart, o2 face mask, Benadryl PO x T. Nurse follow up on 05/19/04 states: ADD: hypersensitivity allergic, ADD Hives, ADD: Reflux.
Six weeks after the second dose of the vaccine I started to have trouble with my right middle finger. It was locking up and clicking. It was not painful and I could still lift weights. It was happening more often and I had to start release it with my left hand. I went to the doctor and he advised that it looked for trigger finger. I tried some exercises and then I got shots for it. It took about two weeks to improve. It is better at the moment. I had never had this problem before.  I also got my eyes checked around the same time I had misplaced my glasses and needed some more. After exam I was referred to a specialist. I am now taking Presur Vision twice daily. I don't know if it is connected.
Rash at the site of injection and then spread throughout body with hives. Reoccurred with second shot. Improved with steroids.
numbness- shoulders, chest, arms, upper back, hands, fingers; joint pain- shoulders, elbows, ankles; This is a spontaneous report from a contactable consumer (patient). A 43-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot/batch no: EW0182) via unspecified route, administered in right arm, as dose 1 single on 06May2021 at 15:30 (at the age of 43-years) for COVID-19 immunization. The most recent COVID-19 vaccine was administered in pharmacy or drug store. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09May2021 10:00, the patient experienced joint pain- shoulders, elbows, ankles and numbness- shoulders, chest, arms, upper back, hands, fingers. The patient received treatment for the events which included steroids, muscle relaxers, therapy and chiropractor. The clinical outcome of the joint pain- shoulders, elbows, ankles and numbness- shoulders, chest, arms, upper back, hands, fingers were not recovered.  Information on batch/lot no. are available. Further information has been requested.
Hospitalized 9/28/21, In recent weeks preceding admission, he reports "everybody in the family" with COVID; he developed fever, nausea/vomiting/diarrhea, fatigue with myalgias and nasal congestion, loss of taste/smell and poor appetite. COVID positive test  on September 26 per him, came to emergency room on September 28, Covid positive again and hypoxic.
A report was received from a healthcare professional on 10/28/2003 concerning a female vaccinee of approximately 48 years of age who experienced overwhelming pain at the injection site immediately after receiving Fluvirin on 24 October 2003. On 24 October 2003 the vaccinee experienced overwhelming pain at the injection site.  An ice pack was applied and the pain decreased to soreness.  The vaccinee had a prior history of influenza vaccination with no adverse events.  The vaccinee recovered on an unspecified date.   There was insufficient information to determine the reporter's causality assessment. Update 1, March 2004 Follow up information received from a healthcare professional indicated that a 65 year old female vaccinee experienced pain at the injection site running down the arm which lasted approximately 15 minutes after receiving Fluvirin. No follow up pending.
APPROX 10 MINUTES POST VACCINATION PT STARTED SHAKING AND FEELING AS THOUGH SHE CAN'T SWALLOW. GAVE 25MG BENADRYL IM. NO IMPROVEMENT WAS NOTED BY PATIENT, SO 25MG MORE BENADRYL WAS GIVEN IM. PT ABLE TO REMAIN SITTING/BREATHING, BUT SHAKEY. PT STATED SHE HAS THIS RXN WITH FIRST DOSE APPROX 40 MINUTES LATER ON DRIVE HOME. THOSE SYMPTOMS RESOLVED ON THEIR OWN WITHIN 10 MINUTES. THIS TIME SYMPTOMS APPEARED SOONER AND LASTED LONGER PER PT. 15 MINUTES AFTER ONSET OF S/S PT STATES SHE IS STARTING TO FEEL BETTER, BUT STILL SHAKING WITH NUMBNESS OF MOUTH, HANDS, LIPS. DRINKING WATER EASILY. PT MONITORED FOR EXTENDED TIME UNTIL S/S RESOLVED PER PT.
LEFT ARM HOT TO TOUCH AND PAINFUL, FEVER 101, NAUSEA, BODY ACHES, HEADACHE, SWEATING, FATIGUE, AND JUST DID NOT FEEL WELL
day p/vax mom noted erythema 3inch diameter;next day erythema w/warmth & tenderness now around arm approx 6-7inches from top margin to lower margin;seen @ ER & given Emycin for cellulitis;erythema w/raised red margin;urticarial like lesions
Neurological problems ,  Bells Palsy, Loss of muscle, taste, smell.  Nerve Issues throughout body
Injection site soreness (first 72 hours); Severe Headache (within first 12 hours), caused a day of missed work; Body aches, extreme fatigue (starting about 72 hours after vaccine and continues to Present (Oct 5th)); Cold Sore (appeared 1 week after vaccine); Nausea (appeared 8 days after vaccine); Extreme body aches, fatigue, nausea, diarhea (ramp up at 9 days after vaccine); Missed work days 9-11 after vaccine. Rapid heart rate (appears 10 days after vaccine.); Visited ER on day 12. No sleep/insomnia (nights 10 and 11 after vaccine).; Chest pain (appears day 11 after vaccine); Visited ER on day 12.
Student complaining of blotchy red rash, noted on hands to just above her elbow.  Student states rash is hot.  Mom did not pick up.  Vital signs remain stable, rash has not spread on any other areas.
Paralysis of Left Arm, and excruciating pain radiating to armpits, and left side of neck and face for about 36 hours. Severe pain of the left arm persisted for the following two days.
Bivalent was given as first dose in series instead of primary. No adverse signs or symptoms reported.
she received PNEUMOVAX 23 "every year"; No additional adverse events reported; This spontaneous report was received from a pharmacist and refers to a female patient of an unknown age. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. Since unknown dates, the patient was vaccinated with doses of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection , every year (dose, route of administration, anatomical localization, lot # and expiration date were unknown) for prophylaxis. No additional adverse events reported.   This is one of two case reports from the same reporter.; Sender's Comments:  US-009507513-2012USA005988:
Pt vax w/DTP/OPV exp seizure day after 2nd DTP. Dx as infantile spasms. F/U 12MAR91:  MOM RECALLED EVENTS & TELLS INFANT HAD SX OF EYE ROLLING & STARTLING EVENING OF VAX.  NOW MOM CERTAIN THESE MVMTS WERE SZ.
Approximately 10 minutes after receiving the COVID-19 Pfizer vaccine, patient informed me that he was feeling "off" and that his hands were erythematous. No other specific symptoms. Denies chest pain, SOB, headaches, dizziness, lip/tongue/throat swelling. No prior history of allergic reaction - save mild atopy. Patient vitals WNL - BP 122/79, O2 saturation 98% RA, HR 71bpm. Patient alert and oriented, speaking in completed sentences without difficulty. Continued to monitor for approx 25 minutes. Patient states he was feeling much better and back to baseline. Hands returned to normal color. Denied any new symptoms and patient feels comfortable to go home. Informed patient to go to ER for onset of symptoms of distress including but not limited to chest pain, SOB, difficulty breathing, dizziness. Reviewed common side effects of the vaccine and symptomatic management. Patient verbalized understanding and had no further questions or concerns at this time.
This spontaneous report was received from an office manager via a company representative concerning a 25 year old female patient. It was reported that the patient was no pregnant. The patient had no pertinent medical history or drug reactions or allergies. On 11-JUN-2015 the patient was vaccinated with a dose of GARDASIL 9 (Lot # K026247; Expiration date: 29-JUN-2017), intramuscular. There were no concomitant medications. On an unspecified date in June 2015, the patient experienced an injection site reaction with localized hardness after receiving GARDASIL 9. The reporter also stated that this was the third dose of the series but that the patient's first and second dose was just GARDASIL, which was other than indicated in the prescribing information. The patient was given BENADRYL as treatment for the adverse events. There were no laboratory tests or diagnostic studies performed. At the time of the report, the patient's outcome was unknown. The patient sought medical attention by a phone call. Additional information has been requested.
Patient got her second booster of Moderna yesterday in her left arm. She states she woke up today and the whole left side of her body is hurting specifically her left ribs and back. She states she also had a fever of 99.1. She states she took tylenol and felt better.
one of the flu symptoms since she went in and took his temperature and it's like 99.5; one of the flu symptoms since she went in and took his temperature and it's like 99.5; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (004756).  A male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 31Oct2023 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFLUENZA (non-serious), PYREXIA (non-serious) all with onset 2023, outcome "unknown" and all described as "one of the flu symptoms since she went in and took his temperature and it's like 99.5". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: She's wondering if it's one of the flu symptoms since she went in and took his temperature and it's like 99.5.   The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Not sure if caused by vaccine but growth double golf ball size on rt side neck. Family doctor not sure.  could not see ENT until Aug 4th.
8 -12 hours of fever of 102 degrees and chills; headache  3.5 weeks later, ED visit on 2/19 at clinic with overnight stay and 2/21 at clinic - with high BP and palpitations; shortness of breath